PHIO PHARMACEUTICALS CORP. Operating Leases, Rent Expense
PHIO PHARMACEUTICALS CORP. (PHIO) reported Operating Leases, Rent Expense of $115.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2018-03-26
- PHIO PHARMACEUTICALS CORP. operating leases, rent expense for fiscal 2017 was $115.00K, a 1.71% decline from fiscal 2016.
- PHIO PHARMACEUTICALS CORP. operating leases, rent expense for fiscal 2016 was $117.00K, a 0.85% decline from fiscal 2015.
- PHIO PHARMACEUTICALS CORP. operating leases, rent expense for fiscal 2015 was $118.00K, a 9.77% increase from fiscal 2014.
- PHIO PHARMACEUTICALS CORP. operating leases, rent expense for fiscal 2014 was $107.50K, a 70.91% increase from fiscal 2013.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2017-12-31 | $115.00K 10-K · filed 2018-03-26 |
| 2016-12-31 | $117.00K 10-K · filed 2018-03-26 |
| 2015-12-31 | $118.00K 10-K · filed 2017-03-30 |
| 2014-12-31 | $107.50K 10-K · filed 2016-03-30 |
| 2013-12-31 | $62.90K 10-K · filed 2015-03-30 |
| 2012-12-31 | $138.00K 10-K · filed 2014-03-28 |
| 2011-12-31 | $220.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |